$164.70 0.3%
ZTS Stock Price vs. AI Score
Data gathered: December 26

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Zoetis (ZTS)

Analysis generated July 14, 2024. Powered by Chat GPT.

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. It was a subsidiary of Pfizer, the pharmaceutical giant, until it was spun off in 2013. The company focuses on the full continuum of animal health: from research and development to production and marketing. It offers a wide range of food animal and companion animal products including vaccines, pharmaceuticals, diagnostic products, genetic tests, and bio-devices.

Read full AI stock Analysis

Stock Alerts - Zoetis (ZTS)

company logo Zoetis | December 3
Employee Rating is down by 2.5% over the last month.
company logo Zoetis | November 27
Insider Alert: Polzer Robert J is selling shares
company logo Zoetis | November 26
Employee Rating is up by 2.6% over the last month.
company logo Zoetis | November 5
Over the past few months, there has been an downward trend in the business outlook.

About Zoetis

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming.


Zoetis
Price $164.70
Target Price Sign up
Volume 1,020,000
Market Cap $74.3B
Year Range $144.84 - $196.01
Dividend Yield 1.21%
PE Ratio 30.96
Analyst Rating 100% buy
Industry Pet Care

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '242.39B1.31B1.08B682M963M0.000
Q2 '242.36B1.3B1.06B624M881M1.560
Q1 '242.19B1.25B943M599M849M1.380
Q4 '232.21B1.36B852M525M756M1.240
Q3 '232.15B1.22B930M596M822M1.360

Insider Transactions View All

Polzer Robert J filed to sell 3,249 shares at $177.5.
November 26 '24
Lagano Roxanne filed to sell 14,800 shares at $151.2.
April 18 '24
Lagano Roxanne filed to sell 15,723 shares at $173.3.
March 18 '24
Reed Willie M filed to sell 9,994 shares at $182.7.
March 12 '24
Lagano Roxanne filed to sell 16,646 shares at $187.3.
February 21 '24

What is the Market Cap of Zoetis?

The Market Cap of Zoetis is $74.3B.

What is Zoetis' PE Ratio?

As of today, Zoetis' PE (Price to Earnings) ratio is 30.96.

What is the current stock price of Zoetis?

Currently, the price of one share of Zoetis stock is $164.70.

How can I analyze the ZTS stock price chart for investment decisions?

The ZTS stock price chart above provides a comprehensive visual representation of Zoetis' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zoetis shares. Our platform offers an up-to-date ZTS stock price chart, along with technical data analysis and alternative data insights.

Does ZTS offer dividends to its shareholders?

Yes, Zoetis (ZTS) offers dividends to its shareholders, with a dividend yield of 1.21%. This dividend yield represents Zoetis' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Zoetis in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Zoetis?

Some of the similar stocks of Zoetis are Chewy, Petco, PetMeds, BARK, and Chewy.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.